Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
wellZin is a proprietary over-the-counter zinc lozenge developed by Adeona Pharmaceuticals as a homeopathic cold remedy intended to reduce the duration and severity of symptoms of the common cold. It contains zinc acetate (approximately 13.3 mg per lozenge) formulated similarly to zinc lozenges previously studied clinically by Ananda Prasad and collaborators, with the therapeutic concept that ionizable zinc in the oropharynx can interfere with rhinovirus replication and modulate local immune responses to shorten illness duration.[4][2][8][10] As an OTC homeopathic product, it is positioned as a symptomatic treatment rather than a prescription pharmaceutical, and development has focused on commercialization and marketing partnerships rather than formal drug approval pathways.[4][6][8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wellZin.